Back to LYEL
UBS Group AG LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
13
Latest value
$824K
Q3 2026
Peak value
$824K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $4K |
| Q3 2025 | $341K |
| Q3 2025 | $65 |
| Q4 2025 | $8K |
| Q4 2025 | $396K |
| Q4 2025 | $3K |
| Q1 2026 | $5K |
| Q1 2026 | $564K |
| Q1 2026 | $70K |
| Q2 2026 | $4K |
| Q2 2026 | $357K |
| Q2 2026 | $5K |
| Q3 2026 | $824K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $824K | 84.1K | — | — |
| Q2 2026 | $5K | 337 | — | — |
| Q2 2026 | $357K | 25.4K | — | — |
| Q2 2026 | $4K | 250 | — | — |
| Q1 2026 | $70K | 3.5K | — | — |
| Q1 2026 | $564K | 28.1K | — | — |
| Q1 2026 | $5K | 250 | — | — |
| Q4 2025 | $3K | 100 | — | — |
| Q4 2025 | $396K | 12.9K | — | — |
| Q4 2025 | $8K | 250 | — | — |
| Q3 2025 | $65 | 4 | — | — |
| Q3 2025 | $341K | 21.0K | — | — |
| Q3 2025 | $4K | 250 | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M